Skip to main content

Advertisement

Log in

Nonsurgical therapy of chronic periodontitis with adjunctive systemic azithromycin or amoxicillin/metronidazole

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

The objective of the present study is to compare the effect of systemic adjunctive use of azithromycin with amoxicillin/metronidazole to scaling and root planing (SRP) in a clinical study.

Materials and methods

Data from 60 individuals with chronic periodontitis were evaluated after full-mouth SRP. Antibiotics were given from the first day of SRP, in the test group (n = 29), azithromycin for 3 days and, in the control group (n = 31), amoxicillin/metronidazole for7 days. Probing depth (PD), attachment level (AL), and bleeding on probing (BOP) were recorded at baseline and after 3 and 12 months. Gingival crevicular fluid was analyzed for matrix metalloprotease (MMP)-8 and interleukin (IL)-1beta levels. Subgingival plaque was taken for assessment of the major bacteria associated with periodontitis.

Results

In both groups, PD, AL, and BOP were significantly reduced (p < 0.001).

A few significant differences between the groups were found; AL and BOP were significantly better in the test than in the control group at the end of the study (p = 0.020 and 0.009). Periodontopathogens were reduced most in the test group.

Conclusions

A noninferiority of the treatment with azithromycin in comparison with amoxicillin/metronidazole can be stated. The administration of azithromycin could be an alternative to the use of amoxicillin/metronidazole adjunctive to SRP in patients with moderate or severe chronic periodontitis; however, a randomized placebo-controlled multicenter study is needed.

Clinical relevance

Application of azithromycin as a single antibiotic for 3 days might be considered as an additional adjunctive antibiotic to SRP in selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Apatzidou DA, Kinane DF (2010) Nonsurgical mechanical treatment strategies for periodontal disease. Dent Clin North Am 54:1–12. doi:10.1016/j.cden.2009.08.006S0011-8532(09)00071-8

    Article  PubMed  Google Scholar 

  2. Cobb CM (2002) Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol 29(Suppl 2):6–16

    PubMed  Google Scholar 

  3. Sgolastra F, Gatto R, Petrucci A, Monaco A (2012) Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontol 83:1257–1269. doi:10.1902/jop.2012.110625

    Article  PubMed  Google Scholar 

  4. Zandbergen D, Slot DE, Cobb CM, Van der Weijden FA (2013) The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review. J Periodontol 84:332–351. doi:10.1902/jop.2012.120040

    Article  PubMed  Google Scholar 

  5. Aljateeli M, Giannobile WV, Wang HL (2013) Locally-delivered antibiotics for management of periodontitis: current understanding. J Mich Dent Assoc 95:42–47

    PubMed  Google Scholar 

  6. Sgolastra F, Severino M, Petrucci A, Gatto R, Monaco A (2014) Effectiveness of metronidazole as an adjunct to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontal Res 49:10–19. doi:10.1111/jre.12089

    Article  PubMed  Google Scholar 

  7. Miranda TS, Feres M, Perez-Chaparro PJ, Faveri M, Figueiredo LC, Tamashiro NS, Bastos MF, Duarte PM (2014) Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1-year outcomes of a randomized placebo-controlled clinical trial. J Clin Periodontol 41:890–899. doi:10.1111/jcpe.12282

    Article  PubMed  Google Scholar 

  8. Preus HR, Scheie AA, Baelum V (2014) Letter to the editor: Re: The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review; Re: Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis; Re: Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-analysis. J Periodontol 85:374–384. doi:10.1902/jop.2014.130379

    Article  PubMed  Google Scholar 

  9. Muniz FW, de Oliveira CC, de Sousa CR, Moreira MM, de Moraes ME, Martins RS (2013) Azithromycin: a new concept in adjuvant treatment of periodontitis. Eur J Pharmacol 705:135–139. doi:10.1016/j.ejphar.2013.02.044S0014-2999(13)00153-2

    Article  PubMed  Google Scholar 

  10. Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R (2014) Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther 143:225–245. doi:10.1016/j.pharmthera.2014.03.003S0163-7258(14)00055-2

    Article  PubMed  Google Scholar 

  11. Gannon SC, Cantley MD, Haynes DR, Hirsch R, Bartold PM (2013) Azithromycin suppresses human osteoclast formation and activity in vitro. J Cell Physiol 228:1098–1107. doi:10.1002/jcp.24259

    Article  PubMed  Google Scholar 

  12. Doyle CJ, Fitzsimmons TR, Marchant C, Dharmapatni AA, Hirsch R, Bartold PM (2015) Azithromycin suppresses P. gingivalis LPS-induced pro-inflammatory cytokine and chemokine production by human gingival fibroblasts in vitro. Clin Oral Investig 19:221–227. doi:10.1007/s00784-014-1249-7

    Article  PubMed  Google Scholar 

  13. Oteo A, Herrera D, Figuero E, O’Connor A, Gonzalez I, Sanz M (2010) Azithromycin as an adjunct to scaling and root planing in the treatment of Porphyromonas gingivalis-associated periodontitis: a pilot study. J Clin Periodontol 37:1005–1015. doi:10.1111/j.1600-051X.2010.01607.xCPE1607

    Article  PubMed  Google Scholar 

  14. Haas AN, de Castro GD, Moreno T, Susin C, Albandar JM, Oppermann RV, Rosing CK (2008) Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial. J Clin Periodontol 35:696–704. doi:10.1111/j.1600-051X.2008.01254.xCPE1254

    Article  PubMed  Google Scholar 

  15. Yashima A, Gomi K, Maeda N, Arai T (2009) One-stage full-mouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin. J Periodontol 80:1406–1413. doi:10.1902/jop.2009.090067

    Article  PubMed  Google Scholar 

  16. Haas AN, Seleme F, Segatto P, Susin C, Albandar J, Oppermann RV, Fontanella VR, Rosing CK (2012) Azithromycin as an adjunctive treatment of aggressive periodontitis: radiographic findings of a 12-month randomized clinical trial. Am J Dent 25:215–219

    PubMed  Google Scholar 

  17. Han B, Emingil G, Ozdemir G, Tervahartiala T, Vural C, Atilla G, Baylas H, Sorsa T (2012) Azithromycin as an adjunctive treatment of generalized severe chronic periodontitis: clinical, microbiologic, and biochemical parameters. J Periodontol 83:1480–1491. doi:10.1902/jop.2012.110519

    Article  PubMed  Google Scholar 

  18. Emingil G, Han B, Ozdemir G, Tervahartiala T, Vural C, Atilla G, Baylas H, Sorsa T (2012) Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis. J Periodontal Res 47:729–739. doi:10.1111/j.1600-0765.2012.01488.x

    Article  PubMed  Google Scholar 

  19. Sampaio E, Rocha M, Figueiredo LC, Faveri M, Duarte PM, Gomes Lira EA, Feres M (2011) Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 38:838–846. doi:10.1111/j.1600-051X.2011.01766.x

    Article  PubMed  Google Scholar 

  20. Schmidt E, Kaciroti N, Loesche W (2011) Benefits of additional courses of systemic azithromycin in periodontal therapy. Gen Dent 59:180–187, quiz 188-9

    PubMed  Google Scholar 

  21. Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6. doi:10.1902/annals.1999.4.1.1

    Article  PubMed  Google Scholar 

  22. Lange DE, Plagmann HC, Eenboom A, Promesberger A (1977) Clinical methods for the objective evaluation of oral hygiene. Dtsch Zahnarztl Z 32:44–47

    PubMed  Google Scholar 

  23. Griffiths GS (2003) Formation, collection and significance of gingival crevice fluid. Periodontol 2000(31):32–42

    Article  Google Scholar 

  24. Eick S, Straube A, Guentsch A, Pfister W, Jentsch H (2011) Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment. Diagn Microbiol Infect Dis 69:12–20. doi:10.1016/j.diagmicrobio.2010.08.017S0732-8893(10)00346-9

    Article  PubMed  Google Scholar 

  25. Yang JL, Wang MS, Cheng AC, Pan KC, Li CF, Deng SX (2008) A simple and rapid method for extracting bacterial DNA from intestinal microflora for ERIC-PCR detection. World J Gastroenterol 14:2872–2876

    Article  PubMed  PubMed Central  Google Scholar 

  26. Moher D, Schulz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191–1194

    Article  PubMed  Google Scholar 

  27. Haffajee AD, Torresyap G, Socransky SS (2007) Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol 34:243–253. doi:10.1111/j.1600-051X.2006.01040.x

    Article  PubMed  Google Scholar 

  28. Axelsson P, Lindhe J (1981) The significance of maintenance care in the treatment of periodontal disease. J Clin Periodontol 8:281–294

    Article  PubMed  Google Scholar 

  29. Gaunt F, Devine M, Pennington M, Vernazza C, Gwynnett E, Steen N, Heasman P (2008) The cost-effectiveness of supportive periodontal care for patients with chronic periodontitis. J Clin Periodontol 35:67–82. doi:10.1111/j.1600-051X.2008.01261.xCPE1261

    Article  PubMed  Google Scholar 

  30. Meyer-Baumer A, Eick S, Mertens C, Uhlmann L, Hagenfeld D, Eickholz P, Kim TS, Cosgarea R (2014) Periodontal pathogens and associated factors in aggressive periodontitis: results 5-17 years after active periodontal therapy. J Clin Periodontol 41:662–672. doi:10.1111/jcpe.12255

    Article  PubMed  Google Scholar 

  31. Tan KH, Seers CA, Dashper SG, Mitchell HL, Pyke JS, Meuric V, Slakeski N, Cleal SM, Chambers JL, McConville MJ, Reynolds EC (2014) Porphyromonas gingivalis and Treponema denticola exhibit metabolic symbioses. PLoS Pathog 10:e1003955. doi:10.1371/journal.ppat.1003955PPATHOGENS-D-13-02117

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ramich T, Schacher B, Scharf S, Rollke L, Arndt R, Eickholz P, Nickles K (2015) Subgingival plaque sampling after combined mechanical and antibiotic nonsurgical periodontal therapy. Clin Oral Investig 19:27–34. doi:10.1007/s00784-014-1208-3

    Article  PubMed  Google Scholar 

  33. Lo Bue AM, Rossetti B, Cali G, Nicoletti G, Condorelli F (1997) Antimicrobial interference of a subinhibitory concentration of azithromycin on fimbrial production of Porphyromonas gingivalis. J Antimicrob Chemother 40:653–657

    Article  Google Scholar 

  34. Maezono H, Noiri Y, Asahi Y, Yamaguchi M, Yamamoto R, Izutani N, Azakami H, Ebisu S (2011) Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis. Antimicrob Agents Chemother 55:5887–5892. doi:10.1128/AAC.05169-11AAC.05169-11

    Article  PubMed  PubMed Central  Google Scholar 

  35. Imperi F, Leoni L, Visca P (2014) Antivirulence activity of azithromycin in Pseudomonas aeruginosa. Front Microbiol 5:178. doi:10.3389/fmicb.2014.00178

    Article  PubMed  PubMed Central  Google Scholar 

  36. Barksby HE, Lea SR, Preshaw PM, Taylor JJ (2007) The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 149:217–225. doi:10.1111/j.1365-2249.2007.03441.x

    Article  PubMed  PubMed Central  Google Scholar 

  37. Sorsa T, Tjaderhane L, Salo T (2004) Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 10:311–318. doi:10.1111/j.1601-0825.2004.01038.x

    Article  PubMed  Google Scholar 

  38. Uitto VJ (2000) Overall CM and McCulloch C (2003) Proteolytic host cell enzymes in gingival crevice fluid. Periodontol 31:77–104

    Article  Google Scholar 

  39. Hall IH, Schwab UE, Ward ES, Butts JD, Wolford ET, Ives TJ (2002) Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes. Int J Antimicrob Agents 20:348–360

    Article  PubMed  Google Scholar 

  40. Polancec DS, Munic Kos V, Banjanac M, Vrancic M, Cuzic S, Belamaric D, Parnham MJ, Polancec D, Erakovic Haber V (2012) Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties. J Leukoc Biol 91:229–243. doi:10.1189/jlb.1210655jlb.1210655

    Article  PubMed  Google Scholar 

  41. Culic O, Erakovic V, Cepelak I, Barisic K, Brajsa K, Ferencic Z, Galovic R, Glojnaric I, Manojlovic Z, Munic V, Novak-Mircetic R, Pavicic-Beljak V, Sucic M, Veljaca M, Zanic-Grubisic T, Parnham MJ (2002) Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur J Pharmacol 450:277–289

    Article  PubMed  Google Scholar 

  42. Ho W, Eubank T, Leblebicioglu B, Marsh C, Walters J (2010) Azithromycin decreases crevicular fluid volume and mediator content. J Dent Res 89:831–835. doi:10.1177/00220345103686500022034510368650

    Article  PubMed  PubMed Central  Google Scholar 

  43. Belibasakis GN, Thurnheer T (2014) Validation of antibiotic efficacy on in vitro subgingival biofilms. J Periodontol 85:343–348. doi:10.1902/jop.2013.130167

    Article  PubMed  Google Scholar 

  44. Tsaousoglou P, Nietzsche S, Cachovan G, Sculean A, Eick S (2014) Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm. J Med Microbiol 63:284–292. doi:10.1099/jmm.0.065441-0jmm.0.065441-0

    Article  PubMed  Google Scholar 

  45. Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M (2014) A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 14:13. doi:10.1186/1471-2334-14-131471-2334-14-13

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors appreciate the laboratory work of Stéphanie Larti, Anna Magdon, and Marianne Weibel. They are grateful to Timothy Jones (Institute of Applied Linguistics and Translatology, University of Leipzig) for proofreading and to Walter B. Bürgin, Dipl. Biomed. Ing. (University of Bern), for statistical support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Holger F. R. Jentsch.

Ethics declarations

Conflict of interest

The authors (Holger Jentsch, Andreas Buchmann, Abel Friedrich, and Sigrun Eick) declare that they have no conflict of interest.

Funding

The study was funded by the participating institutions and partly supported by Hain Diagnostica, Nehren, Germany, who provided the materials for microbiological laboratory analyses.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Holger F. R. Jentsch and Andreas Buchmann contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jentsch, H.F.R., Buchmann, A., Friedrich, A. et al. Nonsurgical therapy of chronic periodontitis with adjunctive systemic azithromycin or amoxicillin/metronidazole. Clin Oral Invest 20, 1765–1773 (2016). https://doi.org/10.1007/s00784-015-1683-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-015-1683-1

Keywords

Navigation